Cargando…
A meritorious integrated medical regimen for hepatic fibrosis and its complications via the systematic review and meta-analysis for Dahuang Zhechong pill-based therapy
BACKGROUND: Hepatic fibrosis is a health challenge due to the absence of satisfactory therapy, especially at the cirrhosis stage. Dahuang Zhechong pill (DHZCP)-based therapy is reportedly a successful treatment for hepatic fibrosis and is even beneficial for the treatment of cirrhosis. Hence, a syst...
Autores principales: | Ye, Zhen, Huang, Qinfeng, She, Yingqi, Hu, Yu, Wu, Mingquan, Qin, Kaihua, Li, Linzhen, Zhang, Chuantao, Zuo, Xiaohong, Wei, Ailing, Mao, Dewen, Ye, Qiaobo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9616118/ https://www.ncbi.nlm.nih.gov/pubmed/36314011 http://dx.doi.org/10.3389/fmed.2022.920062 |
Ejemplares similares
-
Clinical antitumor application and pharmacological mechanisms of Dahuang Zhechong Pill
por: Tian, Yingying, et al.
Publicado: (2023) -
Efficacy and Safety of Dahuang Zhechong Pill in Silicosis: A Randomized Controlled Trial
por: Tang, Wu-Yi-Nuo, et al.
Publicado: (2021) -
Dahuang Zhechong Pills Suppress Silicosis Fibrosis Progression via p38 MAPK/TGF-β1/Smad Pathway In Vitro
por: Wu, Li-Juan, et al.
Publicado: (2021) -
Dahuang Zhechong Pill Combined with Doxorubicin Induces Cell Death through Regulating Energy Metabolism in Human Hepatocellular Carcinoma Cells
por: Wu, Li, et al.
Publicado: (2017) -
Inflammatory Cytokines, Adipocytokines, and Th17/Treg Balance in Patients with Nonalcoholic Fatty Liver Disease following Administration of Dahuang Zhechong Pills
por: Duan, Xiaohua, et al.
Publicado: (2022)